![Takashi Kiyoizumi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takashi Kiyoizumi
Corporate Officer/Principal chez Nihon University
Postes actifs de Takashi Kiyoizumi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nihon University | Corporate Officer/Principal | - | - |
Historique de carrière de Takashi Kiyoizumi
Anciens postes connus de Takashi Kiyoizumi
Sociétés | Poste | Début | Fin |
---|---|---|---|
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Corporate Officer/Principal | - | - |
Tanabe Research Laboratories U.S.A., Inc.
![]() Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | President | - | - |
MEDICINOVA, INC. | President | - | - |
Keio University | Corporate Officer/Principal | - | - |
The San Diego Symphony Orchestra Association
![]() The San Diego Symphony Orchestra Association Movies/EntertainmentConsumer Services The San Diego Symphony performs and conducts concerts and musical orchestra. It also provides corporate sponsorship, outreach programs, and ticket purchasing services. The company was founded on December 6, 1910 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Trius Therapeutics, Inc.
![]() Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Formation de Takashi Kiyoizumi
Massachusetts Institute of Technology | Graduate Degree |
Keio University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Japon | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Graduate Degree | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MEDICINOVA, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Trius Therapeutics, Inc.
![]() Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
The San Diego Symphony Orchestra Association
![]() The San Diego Symphony Orchestra Association Movies/EntertainmentConsumer Services The San Diego Symphony performs and conducts concerts and musical orchestra. It also provides corporate sponsorship, outreach programs, and ticket purchasing services. The company was founded on December 6, 1910 and is headquartered in San Diego, CA. | Consumer Services |
Tanabe Research Laboratories U.S.A., Inc.
![]() Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Health Technology |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
- Bourse
- Insiders
- Takashi Kiyoizumi
- Expérience